Enveda makes ‘exercise pill’ that skips the treadmill
Drug mimics a hormone you make when you push hard at the gym – early results suggest it…
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Summit Therapeutics (NASDAQ:SMMT) requires weighing the broad potential of artificial intelligence against…
Definium LSD therapy for major depression helped patients in Phase 3 trial
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Prometheus, Lilly, Nvidia, Abridge, Luvelta: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
Lilly shares safety, tolerability data on its next-gen obesity drug
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected…
Recursion Pharmaceuticals vs. Schrödinger: Which Healthcare Stock Is a Better Buy in 2026?
As drug discovery moves from trial-and-error to digital simulation, choosing between Recursion Pharmaceuticals (NASDAQ:RXRX) and Schrödinger (NASDAQ:SDGR) depends…
Industry and regulators signal a smarter, collaborative era for supplement oversight
While the industry has spent years bracing for and fending off a heavier regulatory hand, what it heard…
3 Stocks Poised to Disrupt the Healthcare Market by 2030
The biggest mistake investors make with healthcare stocks is assuming the future will look like the past: incremental…
FDA testing speedier drug development with real-time clinical trials
WASHINGTON — The Food and Drug Administration on Tuesday announced efforts to make clinical trials more efficient, starting…
20 Years Of Priority Review Vouchers, A Tool For Spurring Needed Drugs
Collection of sandflies, which can transmit river blindness Universal Images Group via Getty Images Occasionally I’ll go watch…